Melanoma Inhibitory Activity Protein 2 (MIA2) (Middle Region) Peptide
-
- Target See all MIA2 products
- MIA2 (Melanoma Inhibitory Activity Protein 2 (MIA2))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CTAGE5 antibody (Catalog #: ARP47994_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MIA2 (Melanoma Inhibitory Activity Protein 2 (MIA2))
- Synonyms
- MEA6 Peptide, MGEA Peptide, MGEA11 Peptide, MGEA6 Peptide, zgc:56047 Peptide, melanoma inhibitory activity 2 Peptide, CTAGE family, member 5 Peptide, CTAGE family member 5, ER export factor Peptide, MIA2 Peptide, ctage5 Peptide, CTAGE5 Peptide, Mia2 Peptide
- Background
-
CTAGE5 is a tumor-associated antigen.
Alias Symbols: MEA6, MGEA, MGEA11, MGEA6
Protein Size: 761 - Molecular Weight
- 86 kDa
- Gene ID
- 4253
- NCBI Accession
- NM_203355, NP_976230
- UniProt
- O15320
-